| Ticker | $ Bought |
|---|---|
| shoulder innovations | 5,400,040 |
| spdr series trust | 3,406,800 |
| alignment healthcare | 951,025 |
| privia health group | 908,850 |
| Ticker | % Inc. |
|---|---|
| structure therapeutics | 331 |
| anaptysbio inc | 131 |
| tectonic therapeutic | 94.78 |
| instil bio inc | 87.17 |
| immatics nv | 68.69 |
| dexcom inc | 56.82 |
| solid biosciences | 50.16 |
| regeneron pharmctcls | 43.09 |
| Ticker | % Reduced |
|---|---|
| moonlake immunothera | -93.67 |
| mineralys therapeutics | -91.14 |
| rapport therapeutics | -75.83 |
| incyte corporation | -50.00 |
| palvella therapeutic | -48.63 |
| uniqure n.v. | -44.56 |
| zenas biopharma | -27.82 |
| vera therapeutics | -27.11 |
| Ticker | $ Sold |
|---|---|
| lenz therapeutics | -28,643,100 |
| replimune group inc | -2,152,030 |
| io biotech inc | -163,590 |
| tourmaline bio inc | -1,863,000 |
| cvrx inc | -432,180 |
| kestra med technolog | -580,300 |
| viatris inc | -176,814 |
| legend biotech corp | -696,562 |
SECTORAL ASSET MANAGEMENT INC has about 63.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 63.3 |
| Others | 36.2 |
SECTORAL ASSET MANAGEMENT INC has about 35.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 36.2 |
| LARGE-CAP | 20.9 |
| SMALL-CAP | 18.3 |
| MEGA-CAP | 14.7 |
| MID-CAP | 5.3 |
| MICRO-CAP | 4.5 |
About 52.1% of the stocks held by SECTORAL ASSET MANAGEMENT INC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 47.9 |
| S&P 500 | 30.2 |
| RUSSELL 2000 | 21.9 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
SECTORAL ASSET MANAGEMENT INC has 82 stocks in it's portfolio. About 35% of the portfolio is in top 10 stocks. MLTX proved to be the most loss making stock for the portfolio. QURE was the most profitable stock for SECTORAL ASSET MANAGEMENT INC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 2.12 | 14,800 | 3,426,790 | unchanged | 0.00 | ||
| ABT | abbott labs | 1.42 | 17,198 | 2,303,500 | added | 13.16 | ||
| ALHC | alignment healthcare | 0.59 | 54,500 | 951,025 | new | |||
| ALNY | alnylam pharmacuetcl | 0.92 | 3,273 | 1,492,490 | reduced | -1.5 | ||
| AMGN | amgen inc | 1.80 | 10,340 | 2,917,950 | reduced | -8.25 | ||
| ANAB | anaptysbio inc | 3.68 | 194,485 | 5,955,130 | added | 131 | ||
| AXSM | axsome therapeutics | 0.08 | 1,020 | 123,879 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma | 0.44 | 13,650 | 708,981 | reduced | -15.14 | ||
| BGNE | beone medicines ltd | 1.51 | 7,201 | 2,453,380 | reduced | -6.67 | ||
| BIIB | biogen inc | 0.20 | 2,375 | 332,690 | unchanged | 0.00 | ||
| BIL | spdr series trust | 2.10 | 34,000 | 3,406,800 | new | |||
| BMRN | biomarin pharmac inc | 0.84 | 25,030 | 1,355,620 | added | 6.37 | ||
| BMY | bristol myers squibb | 0.30 | 10,800 | 487,080 | unchanged | 0.00 | ||
| BSX | boston scientific | 1.33 | 22,126 | 2,160,160 | added | 4.73 | ||
| CI | the cigna group | 0.32 | 1,800 | 518,850 | unchanged | 0.00 | ||
| CNC | centene corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRSP | crispr therapeutics | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVRX | cvrx inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 0.35 | 10,223 | 561,856 | reduced | -12.8 | ||
| DHR | danaher corp | 1.30 | 10,575 | 2,098,970 | unchanged | 0.00 | ||